Skip to main content

Qiming Venture Partners — Portfolio, Page 7

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

399
Companies
$14.9B
Total invested
$60.5M
Avg. check
34
Industries
Medical 12Biotechnology 8Health Care 7Artificial Intelligence (AI) 6Pharmaceutical 3Semiconductor 3+28 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 145–168 of 399
Qianshou
June 2025

Qianshou is a dating application that helps to find the right partner for life by using artificial matchmaker service.

Apps · Tianjin$30.5M Series B
Tianchen Biotechnology
June 2025

Tianchen Biotechnology is a biotech company that specializes in the development and sales of ophthalmology-related medical products.

Biopharma · Tianjin$27.8M Series C
LongBio Pharma
May 2025

LongBio Pharma is a biotech company that treats patients with an emphasis on complement and allergy diseases.

Biotechnology · Pudong$28.9M Series C
Engitist
May 2025

Jiangling Technology provides high-quality optical measurement and inspection equipment to semiconductor customers around the world.

Information Technology · ChangshuSeries B
Yuanbao Insurance Research Institute
April 2025

Yuanbao is a preferred Internet insurance platform.

Health Insurance · Changyang$1.0M Post Ipo Equity
Yuyao Biotech
April 2025

Yuyao Bio is an innovative drug research and development company.

Biopharma · Shanghai$71.3M Series A
Axera
April 2025

Axera is a hight-tech semiconductor company focused on developing world class Artificial intelligence (AI) SoCs for computer applications.

AI Infrastructure · Beijing$136.1M Series C
Pratilipi
April 2025

Pratilipi is a language storytelling platform that brings readers, writers, and their stories together.

Apps · Bengaluru$12.0M Series E
Insilico Medicine
March 2025

Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.

Artificial Intelligence (AI) · Cambridge$123.0M Series E
Weimei Health
March 2025

Weimei Health is a provider of smart solutions for medical information technology

Artificial Intelligence (AI) · Changping$13.8M Series A
Neuro3 Therapeutics
March 2025

Neuro3 Therapeutics is a Hong Kong based company that advances medicines for CNS diseases.

Medical · Hong Kong$3.5M Seed
TOPI Imaging Technology
March 2025

TOPI Imaging Technology is a medical device firm providing OCT retinal diagnostic system and sweep optical biometer.

Health Care · Beijing$68.6M Series E
DH-Robotics
February 2025

DH-Robotics provides a variety of intelligent grasping and precision motion products and solutions for customers in various industries.

Machinery Manufacturing · Shenzhen$13.7M Series Unknown
Nanos Medical
February 2025

Nanos Medical is a Healthcare Company.

Health Care · Shanghai$41.2M Series Unknown
Vivatides Therapeutics
February 2025

Vivatides Therapeutics develops new RNA treatments to help improve patients' lives using biotechnology research.

Biotechnology · Woburn$10.0M Seed
Miguo AI
January 2025

Miguo AI enhances artificial intelligence in various industries and transforms visual content creation.

Artificial Intelligence (AI) · Tianhe$3.0M Angel
Xi'an Dunbo Medical Equipment
January 2025

Xi'an Dunbo Medical Equipment focuses on the research, development, and production of AI medical devices.

Artificial Intelligence (AI)$5.5M Series A
Xinzeyuan Medical
January 2025

Xinzeyuan Medical is a manufacturer of key precision components and medical endoscope consumables.

Health Care · Hangzhou$10.2M Series B
Insyce
January 2025

Inces is a biotech enterprise focusing on bio-separation technology.

Biotechnology · NanjingSeries C
Iongen Therepeutics
January 2025

Iongen Therepeutics is an innovative drug research and development company focusing on pain treatment.

Health Care · Nanjing$15.0M Seed
Caidya
January 2025

Caidya is a clinical research organization that provides personalized solutions for various therapeutic areas.

Biotechnology · Raleigh$165.0M Private Equity
Windward Bio
January 2025

Windward Bio develops monoclonal antibodies for advanced immunological diseases.

Biotechnology · Basel$200.0M Series A
NASN Automotive Electronics
December 2024

NASN Automotive Electronics is a manufactures automotive electronics and driving related core technology products.

Automotive · Shanghai$68.5M Series D
iMile
November 2024

iMile is a logistics and delivery services provider across the Middle East.

Courier Service · Dubai$56.3M Series C

Where Qiming Venture Partners invests

Medical12
Biotechnology8
Health Care7
Artificial Intelligence (AI)6
Pharmaceutical3
Semiconductor3

About Qiming Venture Partners's portfolio

How many companies has Qiming Venture Partners invested in?▸

Qiming Venture Partners has invested in 399 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Qiming Venture Partners invest in?▸

Qiming Venture Partners's top investment sectors include Medical, Biotechnology, Health Care, Artificial Intelligence (AI), Pharmaceutical. The firm invests across 34 different industry categories.

What is Qiming Venture Partners's largest investment?▸

Among tracked funding rounds, Windward Bio received $200.0M in a Series A round. Qiming Venture Partners's total known invested capital is $14.9B.

What is the average investment size for Qiming Venture Partners?▸

Qiming Venture Partners's average investment size is $60.5M across its portfolio of 399 companies.

What are Qiming Venture Partners's most recent investments?▸

Recent Qiming Venture Partners portfolio additions include Qianshou, Tianchen Biotechnology, LongBio Pharma, Engitist, Yuanbao Insurance Research Institute. These companies were founded in 2020 or later.

Reach the founders behind these 399 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →